Drug Database
N02CC01 sumatriptan
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Imigran 10mg Nasal Spray
- POM Imigran 20mg Nasal Spray
- POM Imigran Injection, Subject
- POM Imigran Radis 100mg Tablets
- POM Imigran Radis 50mg Tablets
- POM Imigran Tablets 100 mg
- POM Imigran Tablets 50mg
- OTC Migraitan 50mg Film-coated Tablets
- OTC MigraKind 50 mg Film-Coated Tablets
- POM Sumatriptan 100 mg Film-coated Tablet
- POM Sumatriptan 100 mg film-coated tablets
- POM Sumatriptan 100mg film-coated Tablets
- POM Sumatriptan 100mg Tablets
- POM Sumatriptan 100mg Tablets
- POM Sumatriptan 3 mg/0.5 ml solution for injection in pre-filled pen
- POM Sumatriptan 50 mg Film coated Tablet
- POM Sumatriptan 50 mg film-coated tablets
- POM Sumatriptan 50mg film-coated Tablets
- POM Sumatriptan 50mg Tablets
- POM Sumatriptan 50mg Tablets
- POM Sumatriptan 6 mg/0.5 ml Solution for Injection
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).